US Patent Issued to Anaka Pharmaceuticals on Aug. 25 for "Combination therapy for treating executive function disorders" (Dominican Inventor)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,714,714, issued on Aug. 25, was assigned to Anaka Pharmaceuticals Inc. (Lexington, Mass.).

"Combination therapy for treating executive function disorders" was invented by Hector Mario Sanchez (Santo Domingo, Dominican Republic).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the treatment of an executive function disorder, such as attention deficit hyperactivity disorder (ADHD) and/or autism with both lacosamide and oxcarbazepine."

The patent was filed on Feb. 3, 2022, under Application No. 18/275,354.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?S...